Package 60505-3801-0

{"route": ["ORAL"], "spl_id": "6c941626-eccb-8cc5-eea9-cf3bc4ee3f0e", "openfda": {"nui": ["N0000175605", "N0000020009", "N0000187062", "N0000182137", "N0000187064", "N0000187063", "N0000191272", "N0000185503"], "upc": ["0360505380152", "0360505380251", "0360505380374"], "unii": ["F41401512X"], "rxcui": ["746606", "997653", "2002717"], "spl_set_id": ["8283672c-619f-fe60-3d25-040f95ac1440"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "UGT1A1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (60505-3801-0)  / 14 CAPSULE in 1 BLISTER PACK", "package_ndc": "60505-3801-0", "marketing_start_date": "20250523"}, {"sample": false, "description": "4 CARTON in 1 CARTON (60505-3801-2)  / 2 BLISTER PACK in 1 CARTON (60505-3801-3)  / 14 CAPSULE in 1 BLISTER PACK", "package_ndc": "60505-3801-2", "marketing_start_date": "20250523"}], "brand_name": "Nilotinib", "product_id": "60505-3801_6c941626-eccb-8cc5-eea9-cf3bc4ee3f0e", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "60505-3801", "generic_name": "nilotinib", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nilotinib", "active_ingredients": [{"name": "NILOTINIB", "strength": "150 mg/1"}], "application_number": "ANDA203640", "marketing_category": "ANDA", "marketing_start_date": "20250523", "listing_expiration_date": "20261231"}